Literature DB >> 19712765

Phenotypic and functional characteristics of HIV-specific CD8 T cells and gag sequence variability after autologous dendritic cells based therapeutic vaccine.

Anna López1, Nils van der Lubbe, Sonsoles Sánchez-Palomino, Mireia Arnedo, Meritxell Nomdedeu, Pedro Castro, Meritxell Guilà, Maria J Maleno, Felipe García, Teresa Gallart, José M Gatell, Montserrat Plana.   

Abstract

A decrease in HIV-1 specific CD8 T-cell responses associated with a partial control of viral replication occurred in 12 HIV-1-infected patients during autologous dendritic cells vaccination. HIV CD8 T cells were detected in 6/10 patients during immunizations, increasing after HAART discontinuation in 3 of them. Tet+ CD8 cells mainly had an effector phenotype (CD45RA-/+ CCR7- and CD28- and Perf+/-) and maintained IFN-gamma release throughout follow-up. By contrast, patients with CD45RA-/+ CCR7+ Perf+ HIV-specific cells showed a decrease in peptide-specific IFN-gamma production during vaccinations while levels were recovered when off HAART. No major mutations in either Gag p24 and p17 immunodominant epitopes were observed that might have explained the impaired CD8+ T-cell responses. Taken together, heterogeneity in the maturation status of HIV-specific CD8 T cells may be partially involved in the drop of peptide-specific IFN-gamma production during immunizations.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19712765     DOI: 10.1016/j.vaccine.2009.08.021

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  3 in total

1.  A therapeutic dendritic cell-based vaccine for HIV-1 infection.

Authors:  Felipe García; Núria Climent; Lambert Assoumou; Cristina Gil; Nuria González; José Alcamí; Agathe León; Joan Romeu; Judith Dalmau; Javier Martínez-Picado; Jeff Lifson; Brigitte Autran; Dominique Costagliola; Bonaventura Clotet; Josep M Gatell; Montserrat Plana; Teresa Gallart
Journal:  J Infect Dis       Date:  2011-01-13       Impact factor: 5.226

2.  Generation and characterization of a defective HIV-1 Virus as an immunogen for a therapeutic vaccine.

Authors:  Carmen Álvarez-Fernández; Alberto Crespo Guardo; Javier García-Pérez; Felipe García; Julia Blanco; Laura Escribà-García; Jose Maria Gatell; Jose Alcamí; Montserrat Plana; Sonsoles Sánchez-Palomino
Journal:  PLoS One       Date:  2012-11-07       Impact factor: 3.240

3.  Use of RT-defective HIV virions: new tool to evaluate specific response in chronic asymptomatic HIV-infected individuals.

Authors:  Alberto Crespo Guardo; Carmen Alvarez-Fernández; Hodei Arberas; Javier García-Pérez; Felipe García; Manuel Enric Bargalló; María José Maleno; José María Gatell; Beatriz Mothe; José Alcami; Sonsoles Sánchez-Palomino; Montserrat Plana
Journal:  PLoS One       Date:  2013-03-14       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.